Pre-validation of SENS-IS assay for in vitro skin sensitization of medical devices. (March 2021)
- Record Type:
- Journal Article
- Title:
- Pre-validation of SENS-IS assay for in vitro skin sensitization of medical devices. (March 2021)
- Main Title:
- Pre-validation of SENS-IS assay for in vitro skin sensitization of medical devices
- Authors:
- Pellevoisin, C.
Cottrez, F.
Johansson, J.
Pedersen, E.
Coleman, K.
Groux, H. - Abstract:
- Abstract: According to ISO 10993-1:2018, the skin sensitization potential of all medical devices must be evaluated, and for this endpoint ISO 10993-10:2010 recommends the use of in vivo assays. The goal of the present study was to determine if the in vitro SENS-IS assay could be a suitable alternative to the current in vivo assays. The SENS-IS assay uses the Episkin Large and SkinEthic RHE reconstructed human epidermis models to evaluate marker genes. In our study, the SENS-IS assay correctly identified 13 sensitizers spiked in a non-polar solvent. In a subsequent analysis six medical device silicone samples previously impregnated with sensitizers were extracted with polar and non-polar solvents. The SENS-IS assay correctly identified five of these extracts, while a sixth extract, which contained the weak sensitizer phenyl benzoate, was classified as negative. However, when this extract was concentrated, or a longer exposure time was used, the assay was able to detect phenyl benzoate. The SENS-IS assay was transferred to a naïve laboratory which correctly identified sensitizers in six blinded silicone samples, including the one containing phenyl benzoate. In light of these results, we conclude that the SENS-IS assay is able to correctly identify the presence of sensitizers in medical devices extracts. Highlights: Skin sensitization is a required biocompatibility endpoint for all medical devices with direct or indirect body contact. The SENS-IS assay using reconstructed humanAbstract: According to ISO 10993-1:2018, the skin sensitization potential of all medical devices must be evaluated, and for this endpoint ISO 10993-10:2010 recommends the use of in vivo assays. The goal of the present study was to determine if the in vitro SENS-IS assay could be a suitable alternative to the current in vivo assays. The SENS-IS assay uses the Episkin Large and SkinEthic RHE reconstructed human epidermis models to evaluate marker genes. In our study, the SENS-IS assay correctly identified 13 sensitizers spiked in a non-polar solvent. In a subsequent analysis six medical device silicone samples previously impregnated with sensitizers were extracted with polar and non-polar solvents. The SENS-IS assay correctly identified five of these extracts, while a sixth extract, which contained the weak sensitizer phenyl benzoate, was classified as negative. However, when this extract was concentrated, or a longer exposure time was used, the assay was able to detect phenyl benzoate. The SENS-IS assay was transferred to a naïve laboratory which correctly identified sensitizers in six blinded silicone samples, including the one containing phenyl benzoate. In light of these results, we conclude that the SENS-IS assay is able to correctly identify the presence of sensitizers in medical devices extracts. Highlights: Skin sensitization is a required biocompatibility endpoint for all medical devices with direct or indirect body contact. The SENS-IS assay using reconstructed human epidermis (RhE) models has been adapted for testing medical device extracts. The SENS-IS assay correctly identified 13 sensitizers spiked in polar (NaCl) or non-polar (sesame oil) solvents. The SENS-IS assay correctly classified 5 of 6 materials impregnated with weak, moderate, strong or extreme sensitizers. A blinded study for extracts of the same materials performed in a naïve laboratory produced excellent results. … (more)
- Is Part Of:
- Toxicology in vitro. Volume 71(2021)
- Journal:
- Toxicology in vitro
- Issue:
- Volume 71(2021)
- Issue Display:
- Volume 71, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 71
- Issue:
- 2021
- Issue Sort Value:
- 2021-0071-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-03
- Subjects:
- Toxicity testing -- In vitro -- Periodicals
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08872333 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tiv.2020.105068 ↗
- Languages:
- English
- ISSNs:
- 0887-2333
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.043400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15497.xml